Embecta Valuation
Is EMBC * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMBC * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMBC * (MX$497.96) is trading above our estimate of fair value (MX$90.13)
Significantly Below Fair Value: EMBC * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMBC *?
Other financial metrics that can be useful for relative valuation.
What is EMBC *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.19b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.3x |
Enterprise Value/EBITDA | 7.9x |
PEG Ratio | 0.9x |
Price to Earnings Ratio vs Peers
How does EMBC *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 16.1x | ||
MEDICA B Médica Sur. de | 7.5x | 5.6% | Mex$4.1b |
8086 Nipro | 18x | 10.7% | JP¥200.2b |
6491 Pegavision | 20.3x | 17.7% | NT$37.1b |
301371 Harbin Fuerjia Technology | 18.6x | 11.2% | CN¥13.8b |
EMBC * Embecta | 25.3x | 28.4% | Mex$1.2b |
Price-To-Earnings vs Peers: EMBC * is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the peer average (24.8x).
Price to Earnings Ratio vs Industry
How does EMBC *'s PE Ratio compare vs other companies in the Global Medical Equipment Industry?
Price-To-Earnings vs Industry: EMBC * is good value based on its Price-To-Earnings Ratio (25.3x) compared to the Global Medical Equipment industry average (29.9x).
Price to Earnings Ratio vs Fair Ratio
What is EMBC *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 25.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EMBC *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.